Termination Press Releases. Subject to the provisions of Section 10.5, the Parties shall cooperate in good faith to coordinate public disclosure of the termination of this Agreement and the reasons therefor, and neither Party shall, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Graphite Bio, Inc.), License and Collaboration Agreement (Oyster Point Pharma, Inc.), License and Collaboration Agreement (Milestone Pharmaceuticals Inc.)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.56.3.1, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 3 contracts
Samples: License Agreement (XOMA Corp), License Agreement (XOMA Corp), License Agreement (XOMA Corp)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.510.3, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Zai Lab LTD), License and Collaboration Agreement (Five Prime Therapeutics Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason, and subject to the provisions of Section 10.510.3, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Zai Lab LTD), License and Collaboration Agreement (NovoCure LTD)
Termination Press Releases. Subject to the provisions of Section 10.511.5, the Parties shall cooperate in good faith to coordinate public disclosure of the termination of this Agreement and the reasons therefor, and neither Party shall, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Cytokinetics Inc), License and Collaboration Agreement (Cytokinetics Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.512.5, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Cytokinetics Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions terms of Section 10.511.7.1 (Press Release), the Parties shall will cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallwill not, except to the extent required by Applicable LawsLaw, disclose any such information without the prior approval of the other Party. The In any such disclosures, the Parties will observe the principles to be observed in such disclosures shall be of accuracy, compliance with Applicable Laws Law, and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of this Section 10.512.4, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shall, except to the extent required by Applicable Laws, shall not disclose any such information without the prior approval of the each other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.511.5, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Cytokinetics Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions terms of Section 10.511.9.1 (Press Release), the Parties shall will cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallwill not, except to the extent required by Applicable LawsLaw, disclose any such information without the prior approval of the other Party. The In any such disclosures, the Parties will observe the principles to be observed in such disclosures shall be of accuracy, compliance with Applicable Laws Law, and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Blueprint Medicines Corp)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.513.5, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Cytokinetics Inc)
Termination Press Releases. Subject to In the provisions event of Section 10.5any termination of this Agreement for any reason, the Parties shall cooperate in good faith to coordinate public disclosure disclosure, if any, of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable laws or the rules of a recognized stock exchange, disclose any such information without the prior approval of the other Party. The principles , such approval not to be observed in such disclosures shall be accuracyunreasonably withheld, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such newsconditioned or delayed.
Appears in 1 contract
Samples: License Agreement (Santarus Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.5, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction reactions to such news.
Appears in 1 contract
Samples: Development and Co Commercialization Agreement (Arcturus Therapeutics Ltd.)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.59.5, the Parties shall cooperate in good faith to coordinate public disclosure of the termination of this Agreement and the reasons thereforsuch termination, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Newlink Genetics Corp)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.5this Article 12, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: Exclusive License Agreement (Allogene Therapeutics, Inc.)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.514.2, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Law, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws applicable Law and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction reactions to such news.
Appears in 1 contract
Samples: Collaboration and Option Agreement (Cytokinetics Inc)
Termination Press Releases. Subject In the event of any termination of this Agreement (whether in its entirety or as to the provisions of Section 10.5a particular country) for any reason, the Parties shall cooperate in good faith to coordinate public disclosure disclosure, if any, of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Lawsapplicable Laws or the rules of a recognized stock exchange, disclose any such information without the prior approval of the other Party. The principles , such approval not to be observed in such disclosures shall be accuracyunreasonably withheld, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such newsconditioned or delayed.
Appears in 1 contract
Samples: License Agreement (Tranzyme Inc)
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.59.4, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Termination Press Releases. Subject In the event of termination of this Agreement for any reason and subject to the provisions of Section 10.59.6, the Parties shall cooperate in good faith to coordinate public disclosure of the such termination of this Agreement and the reasons therefor, and neither Party shallshall not, except to the extent required by Applicable Laws, disclose any such information without the prior approval of the other Party. The principles to be observed in such disclosures shall be accuracy, compliance with Applicable Laws and regulatory guidance documents, and reasonable sensitivity to potential negative investor reaction to such news.
Appears in 1 contract
Samples: License and Collaboration Agreement (Five Prime Therapeutics Inc)